The effect of nebulized dexmedetomidine and analgesic in neonatal undergoing fiberoptic bronchoscopy or bronchoalveolar lavage

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2400093215

Enrollment

Unknown

Registered

2024-11-29

Start date

2024-12-01

Completion date

Unknown

Last updated

2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary infections

Interventions

Dexmedetomidine group(DEX group):Nebulized inhalation of dexmedetomidine

Control group:Equal volume of saline was used as blank control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Age of admission <= 28 days; 2.Treated with mechanical ventilation with an indication for flexible bronchoscopy; 3.informed consent from the patient’s guardian

Exclusion criteria

Exclusion criteria: 1.with severe cardiovacular, cerebrovascular system diseases or liver and renal dysfunction; 2. with severe bleeding disorders, coagulation dysfunction, malignant hyperthermia, and respiratory malformations; 3.with congenital or neurological diseases; 4.patients are allergic to anesthetic drugs or intolerant to surgery

Design outcomes

Primary

Measure	Time frame
Neonatal Pain, Agitation and Sedation Scale, N-PASS score;	—

Secondary

Measure	Time frame
adverse reactions;	—

Countries

China

Contacts

Public ContactLin Jiajia

Fujian Children's Hospital

119677043@qq.com+86 158 8003 2623

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026